Domingues-Silva Beatriz, Silva Bruno, Azzalin Claus M
Instituto de Medicina Molecular João Lobo Antunes (iMM), Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
Front Mol Biosci. 2019 Sep 6;6:84. doi: 10.3389/fmolb.2019.00084. eCollection 2019.
The human FANCM ATPase/translocase is involved in various cellular pathways including DNA damage repair, replication fork remodeling and R-loop resolution. Recently, reports from three independent laboratories have disclosed a previously unappreciated role for FANCM in telomerase-negative human cancer cells that maintain their telomeres through the Alternative Lengthening of Telomeres (ALT) pathway. In ALT cells, FANCM limits telomeric replication stress and damage, and, in turn, ALT activity by suppressing accumulation of telomeric R-loops and by regulating the action of the BLM helicase. As a consequence, FANCM inactivation leads to exaggerated ALT activity and ultimately cell death. The studies reviewed here not only unveil a novel function for human FANCM, but also point to this enzyme as a promising target for anti-ALT cancer therapy.
人类FANCM ATP酶/转位酶参与多种细胞途径,包括DNA损伤修复、复制叉重塑和R环解析。最近,三个独立实验室的报告揭示了FANCM在端粒酶阴性的人类癌细胞中的一个以前未被认识到的作用,这些癌细胞通过端粒替代延长(ALT)途径维持其端粒。在ALT细胞中,FANCM限制端粒复制应激和损伤,进而通过抑制端粒R环的积累和调节BLM解旋酶的作用来限制ALT活性。因此,FANCM失活会导致ALT活性过度增强并最终导致细胞死亡。本文综述的研究不仅揭示了人类FANCM的新功能,还指出该酶是抗ALT癌症治疗的一个有前景的靶点。